Diversify Advisory Services LLC Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Diversify Advisory Services LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,283 shares of the healthcare conglomerate's stock after selling 2,132 shares during the quarter. Diversify Advisory Services LLC's holdings in UnitedHealth Group were worth $3,272,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Diversify Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 16.0% during the fourth quarter. Diversify Wealth Management LLC now owns 12,166 shares of the healthcare conglomerate's stock valued at $6,335,000 after purchasing an additional 1,678 shares in the last quarter. City Holding Co. boosted its holdings in shares of UnitedHealth Group by 4.5% during the 4th quarter. City Holding Co. now owns 12,222 shares of the healthcare conglomerate's stock valued at $6,182,000 after acquiring an additional 522 shares during the last quarter. Annex Advisory Services LLC raised its holdings in shares of UnitedHealth Group by 30.0% during the fourth quarter. Annex Advisory Services LLC now owns 54,550 shares of the healthcare conglomerate's stock valued at $27,595,000 after purchasing an additional 12,595 shares during the last quarter. Client 1ST Advisory Group LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth approximately $292,000. Finally, Brady Martz Wealth Solutions LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $978,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.1 %

NYSE UNH traded down $0.56 on Monday, hitting $510.03. 7,462,712 shares of the stock were exchanged, compared to its average volume of 5,104,531. The firm has a market capitalization of $469.37 billion, a P/E ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62. The stock has a fifty day moving average price of $549.37 and a two-hundred day moving average price of $563.70. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on UNH. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. Finally, HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.